Search

Home > The Bio Report > How Faulty Thinking Can Derail Life Sciences M&A Deals
Podcast: The Bio Report
Episode:

How Faulty Thinking Can Derail Life Sciences M&A Deals

Category: Business
Duration: 00:22:41
Publish Date: 2017-11-16 12:33:20
Description: Merger and acquisitions may be a path to creating value for life science companies, but talks can breakdown because of flaws in management thinking that skew their sense of the value of their company. Oded Ben-Joseph, managing director of Outcome Capital, applied behavioral economics to the M&A front to discuss how cognitive biases can derail M&A transactions in an article in the September issue of In Vivo. We spoke to Ben-Joseph about cognitive biases, why the life sciences sector is particularly prone to the problem, and what executives can do to minimize their effects.
Total Play: 0

Some more Podcasts by Levine Media Group

600+ Episodes